semaglutide risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving or a Dipeptidyl Peptidase 4 Inhibitor | Advances in Therapy Semaglutide: Double-edged Sword with Risks

some devices do not require pinching) For standard pen devices that require a skinfold, gently pinch the skin on the back of your upper arm Hold the device as instructed in your specific product information Insert the needle according to your device instructions Press the injection button and hold for the full duration specified (typically 510 seconds for pens

Do Wegovy and Ozempic have the same side effects

Phase 3 trials are ongoing as of 2026, and the compound is not yet approved for clinical use it remains a research compound in active late-phase development

These effects generally improve over time

A thorough review of your health history, current medications, and metabolic markers before starting treatment is not bureaucratic overhead